confidential hospital glucose monitoring system hospital glucose meter no. 260 statstrip glucose rev...
TRANSCRIPT
Confidential
Hospital Glucose Monitoring System
Hospital Glucose Meter
Hospital Glucose Meter
No. 260 StatStrip Glucose Rev 10/04/2012
Confidential
1978 First biosensor for Ionized Calcium1980 First biosensor to measure Chloride in blood1984 First biosensor to measure Total Calcium1985 First biosensor to measure Hematocrit by ISE/Conductivity1987 First biosensor to directly measure whole blood Glucose1988 First biosensor to measure Lithium1990 First biosensor to measure BUN (urea)1992 First biosensor to directly measure whole blood Lactate1994 First biosensor to measure Ionized Magnesium1996 First biosensor to measure Creatinine1996 First biosensor to measure Total CO2 in whole blood1997 First multi-wavelength fiber optic SO2% assay1998 First fiber optic Hemoglobin assay1998 First Ammonium biosensor1999 First non-diluting direct Glutamine biosensor1999 First non-diluting direct Glutamate biosensor2001 First Acetate biosensor2005 First Hematocrit corrected Glucose strip2007 First calibration free Glucose strip2007 First Creatinine strip and meter2009 First calibration free Ketone strip2009 First IgG assay on a biotechnology analyzer2011 First Hematocrit corrected hospital Lactate meter and strip
Nova BioSensor Firsts
Nova is the World Leader in Whole Blood Biosensors
Confidential
Nova Brand Products
Stat Profile® pHOxTest Menu: pH, PCO2, PO2, SO2%, Hct,Hb, Na+, K+, Cl-, Ca++, Glu, Lac
Samples: Whole blood, Serum, Plasma
Nova Chemistry AnalyzersTest Menu: Na+, K+, Cl-, TCO2, Ca++, Mg++, Li+, TCa, Glu, BUN, Crea, Hct, pH
Samples: Whole blood, Serum, Plasma
Nova BioProfile FLEX™ Test Menu: Gluc, Lac, Gln, Glu, NH4+, pH,PO2, PCO2, Na+, K+, Ca++, CD, CV, Osm,IgG, PO4
Samples: Cell Culture Media
Nova MAX® Link ®
Test Menu: GlucoseSamples: Whole blood
Nova StatStrip®
Test Menu: LactateSamples: Whole blood
* Currently Available outside the U.S.
Nova Lactate Plus ®
Test Menu: LactateSamples: Whole blood
Nova StatStrip®
Test Menu: GlucoseSamples: Whole blood
Nova MAX® PlusTest Menu: Glucose/Ketone
Samples: Whole blood
Nova StatStrip®
Test Menu: Glucose/KetoneSamples: Whole blood
Nova StatSensor®
Test Menu: CreatinineSamples: Whole blood
*
Stat Profile® pHOx UltraTest Menu: pH, PCO2, PO2, SO2%, Hct,Hb, Na+, K+, Cl-, Ca++, Mg++, TCO2, Glu,BUN, Creat, Lac, HHb, O2Hb, Methb,COHb, O2Ct, O2Cap, tBilSamples: Whole blood, Serum, Plasma
Confidential
Hospital Laboratory Instrument Platform
Confidential
Hospital Laboratory Instrument Platform
Confidential
Hospital Laboratory Platform
Confidential
Hospital Point-of-Care Glucose Meter
Confidential
Hospital Point-of-Care Lactate Meter
Confidential
Hospital Point-of-Care Creatinine MeterHospital Point-of-Care Creatinine Meter
Confidential
Nova Max® PlusHome Glucose Monitor
Nova Max Link®
Home Glucose Wireless Monitor
®
Confidential
Professional Lactate Meter
Confidential
Nova Handheld Point-of-Care Hospital Analyzers
*
Confidential
Nova Multi-Well
Technology CreatesA New Level of Analytical Performance
Hospital Glucose Meter
Hospital Glucose Meter
TM
Confidential
Laboratory quality accuracy and precision from 10 to 600 mg/dL
Measures and corrects interferences from: - Hematocrit
- Electrochemical interferences including acetaminophen, ascorbic acid, and uric
acid
No maltose, galactose, xylose or oxygen interference
Eliminates calibration codes
Fastest results, 6 seconds
Small sample, 1.2 µL whole blood
Nova Connects™, Total POC Connectivity Solution
StatStrip® Hospital Connectivity Meter
Hospital Glucose Meter
The World’s Most Accurate Hospital Glucose MeterProven in Over 60 Published Hospital Evaluations Worldwide
Confidential
StatStrip® Has Earned Worldwide Scientific Acclaim
Confidential
Plasma Glucose Reference Method
Nov
a St
atS t
rip W
hole
Blo
od G
luco
se
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07
StatStrip® Multi-Well Technology Correlation Study
R2: 0.9950SLOPE: 1.018 INTERCEPT: -0.04 mmol/LINTERCEPT: -0.716 mg/dLN=1703 Sy*x = 0.54 mmol/L
Sy*x = 9.795 mg/dL
TM
(mm
ol/L
)
(mg/
dL)
(mg/dL)
700
700 600
600
400
300
200
100
0 0 100 200 300 400 500
500
33.3 5.6 11.1 16.7 22.2 27.8 38.9
33.3
22.2
16.7
11.1
5.6
27.8
38.9
(mmol/L)
Confidential
Abbott PCx Correlation Study
R2: 0.9499SLOPE: 0.89 INTERCEPT: 0.00 mmol/LINTERCEPT: 0.084 mg/dLN=559 Sy*x = 1.84 mmol/L
Sy*x = 33.194 mg/dL
700
600
400
300
200
100
500
0 6000 100 200 300 400 500
Plasma Glucose Reference Method
Abb
ott P
Cx
Who
le B
lood
Glu
cose
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07
38.9
33.3
22.2
16.7
11.1
5.6
27.8
(mg/
dL)
(mg/dL)
(mmol/L)
(mm
ol/L
)
33.3 5.6 11.1 16.7 22.2 27.8
Confidential
Abbott PXP Correlation Study Sy*x = 1.8 mmol/LSy*x = 33.15 mg/dL
Plasma Glucose Reference Method
Abb
ott P
XP W
hole
Blo
od G
luco
se
R2: 0.97259SLOPE: 0.820 INTERCEPT: 1.05 mmol/L INTERCEPT: 18.886 mg/dL
N=225
0
100
200
300
400
500
600
0 100 200 300 400 500 600
(mg/
dL)
(mg/dL)
(mmol/L)
(mm
ol/L
)
5.6 11.1 16.7 22.2 27.8 33.3
5.6
11.1
16.7
22.2
27.8
33.3
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07
Confidential
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07
LifeScan SureStep Correlation Study
R2: 0.9869SLOPE: 1.029 INTERCEPT: - 0.08 mmol/LINTERCEPT: - 1.505 mg/dLN=628 Sy*x = 0.86 mmol/L
Sy*x = 15.532 mg/dL
Plasma Glucose Reference Method
700
600
400
300
200
100
0
500
600 0 100 200 300 400 500
Life
S ca n
Who
le B
lood
Gl u
cose
38.9
(mmol/L) 33.3 5.6 11.1 16.7 22.2 27.8
33.3
22.2
16.7
11.1
5.6
27.8
(mm
ol/L
)
(mg/dL)
(mg/
dL)
Confidential
Plasma Glucose Reference Method
Roc
he W
h ole
Bl o
od G
luc o
s e
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07
Roche Accu-Chek Correlation Study R2: 0.9795SLOPE: 1.036 INTERCEPT: 0.28 mmol/L
INTERCEPT: 5.002 mg/dLN=273 Sy*x = 1.18 mmol/LSy*x = 21.197 mg/dL
700
600
400
300
200
100
0
500
600 0 100 200 300 400 500
38.9
(mmol/L)
33.3 5.6 11.1 16.7 22.2 27.8
33.3
22.2
16.7
11.1
5.6
27.8
(mm
ol/L
)
(mg/dL)
(mg/
dL)
Confidential
N Slope Intercept(mg/dL)
R2 Sy*x(mg/dL)
Nova 1703 1.018 -0.716 0.995 9.795
Abbott PCx 559 0.89 0.084 0.9499 33.194
Abbott PXI P 225 0.82 18.886 0.97259 33.15
Roche 273 1.036 5.002 0.9795 21.197
LifeScan 628 1.029 -1.505 0.9869 15.532
Summary
StatStrip® Correlation Study Comparison
Kost, G. et al AACC, July 07;Diabetes Technology, Oct 07*
* Summary table did not appear in publication
Confidential
Hematocrit Interference Effect
% Hct 45
Glucose ResultsNormal
(Calibration Point)% Hct 25
Glucose ResultsArtificially High
Up to 25%
% Hct 65
Glucose ResultsArtificially Low
Up to 30%
Hematocrit Interference Effect
StatStrip® Multi-WellTM Technology Measures and Corrects Hematocrit Interference
Confidential
StatStrip® Multi-WellTM Technology Measures and Corrects Hematocrit Interference
-30%
-20%
-10%
0%
10%
20%
30%
25% 60%45%
Error % Due to Uncorrected Hematocrit
Glucose resultuncorrected for Hct.
Glucose result.Hct measuredand corrected.
Hematocrit
Err
or
fro
m H
ct
Low hematocrit causes erroneously high glucose resultsHigh hematocrit causes erroneously low glucose results
Confidential
StatStrip® Multi-WellTM Technology Measures and Corrects Hematocrit Interference
Karon, B. et al, Diabetes Technology and Therapeutics, Apr 2008
Hematocrit Interference StudyNova StatStrip® vs. Current Technology Test Strips
Hematocrit (%)
Mea
n gl
ucos
e di
ffere
nce
(mg/
dL)
-20
-15
-10
-5
0
5
10
15
20 30 40 50 60 70-
-
-
-
Glucose = 54 mg/dL
StatStrip Abbott Precision Lifescan SureStepRoche Inform
True value
Confidential
StatStrip GD Electrochemical GO PhotometricGD Electrochemical StatStrip Abbott Precision Lifescan SureStepRoche Inform
Karon, B. et al, Diabetes Technology and Therapeutics, Apr 2008;
Hematocrit Interference StudyNova StatStrip® vs. Current Technology Test Strips
StatStrip® Multi-WellTM Technology Measures and Corrects Hematocrit Interference
-50
-40
-30
-20
-10
10
20 30 40 50 60 70Hematocrit (%)
Mea
n gl
ucos
e di
ffere
nce
(%)
-
-
-
-
-
Glucose = 247 mg/dLTrue value 0
Confidential
StatStrip® Multi-WellTM Technology Measures and Corrects Hematocrit Interference
-50
-40
-30
-20
-10
10
20 30 40 50 60 70Hematocrit (%)
Mea
n gl
ucos
e di
ffere
nce
(%)
Glucose = 486 mg/dL
Karon, B. et al, Diabetes Technology and Therapeutics, Apr 2008
Hematocrit Interference StudyNova StatStrip® vs. Current Technology Test Strips
StatStrip Abbott Precision Lifescan SureStepRoche Inform
0 True value
Confidential
Severe hematocrit abnormalities are extremely common in hospitalized patients
Up to 77% of ICU patients an have abnormally low hematocrit (<36%) during their ICU stay1,2
Average HCT at ICU admission: 33-34%2,3
29% have HCT<30%4
HCT declines by an average of 1.5 - 2.0% HCT per ICU day1
1. Von Ahsen N et. al., Important role of non-diagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients; Critical Care Medicine: 1999; 27(12); 2630-26392.Corwin HL et. al., The Crit Study: Anemia and blood transfusion in the critically ill; current practice in the United States;, Crit Care Med. 2004 Jan;32(1):30-52 3. T.S. Walsh et. al., Anemia during critical illness;, et. al., British Journal of Anaesthesia 2006, 97(3):278-2914. Vincent JL, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002 Sep 25; 288(12):1499-1507
Confidential
Maltose Interference with Glucose Dehydrogenase (PQQ Mediator) Enzymes
FDA issued two “Public Health Notices” regarding the dangers of GDH-PQQ glucose test strips.
Between 2004 and 2009,thirteen deaths have been reported directly related to the use of GDH-PQQ glucose strips.
On August 13, 2009, the FDA clearly stated “Avoid using GDH-PQQ glucose test strips in healthcare facilities”
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm
Confidential
290 Bed MA Hospital
Maltose Interference StudiesNova StatStrip® vs Roche GDH-PQQ Method
Glu
cose
(mg/
dL)
Glu
cose
(mg/
dL)
Glu
cose
(mg/
dL)
Maltose Interference
54
108
163
0 100 200
Maltose (mg/dL)
Roche
Maltose Interference
217
280
344
Maltose (mg/dL)
Maltose Interference
380
460
540
Maltose (mg/dL)
StatStrip RocheGDH
StatStrip GDH
StatStrip GDH
StatStrip GDH
0 100 200
0 100 200
150 Bed CT Hospital
Glu
cose
(mg/
dL)
Glu
cose
(mg/
dL)
Glu
cose
(mg/
dL)
Maltose Interference
54
120
180
0 100 200
Maltose (mg/dL)
Maltose Interference
199
271
344
0 100 200
Maltose (mg/dL)
380
450
522
0
Maltose (mg/dL)
Maltose Interference
StatStrip GDH
StatStrip GDH
StatStrip GDH
100 200
Confidential
StatStrip lots are interchangeable
Eliminates need for lot change over studies
Reduces operator steps
Eliminates glucose errors due to miscoding
Glucose errors as large as 43% can be caused by an incorrect cal code
Baum JM et al. Diabet Technol & Ther 2006
Nova StatStrip® Multi-Well TechnologyEliminates Calibration Codes
TM
Confidential
24 month shelf-life from manufacturer
180 day open vial stability
Manufacturing lot size up to
8 million strips
Nova StatStrip® Multi-Well TechnologyOffers Other Operational Advantages
TM
Confidential
Nova StatStrip® Multi-Well Technology Creates Significant Performance Improvements
Top Layer– Prevents biohazard exposure– Vent hole creates fast sample draw
Capillary Layer– 1.2 µL sample fill– Design eliminates overfill errors
Measurement Wells LayerWell 1: Interferences and
glucoseWell 2: InterferencesWell 3: Hematocrit Well 4: Reference (and initiates
analysis to eliminate short sampling errors)
Gold Layer– Noble metal; superb electrochemical stability
in all conditions– Classic electrochemical measuring surface– Excellent electrical properties
Patent: US#6,287,451;6,837,976;EP#1 212 609;CA 2,375,092
TM
Confidential
“POCT glucose meters have now been employed for making therapeutically important insulin dosing decisions. It is essential that the accuracy of these measurements be comparable to those of laboratory analyzers..”
Khan A.I. 2006
“Careful assessment of glucose measurement and how it may impact the targets selected in the hospital are critical safety issues in intensive management of hyperglycemia.” Dungan K. 2007
Khan AI et al. The Variability of Results Between Point-of-Care Testing Glucose Meters and the Central Laboratory Analyzer. Arch Pathol Lab Med, Vol 130, Oct 2006
Dungan K et al. Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management. Diabetes Care, Vol 30, Number 2, Februaly 2007
Glucose Management of Hospitalized Patients Demands Improved Glucose Strip Performance
JCAHO considers insulin to be one of the highest risk medicines in the inpatient setting
Confidential
“The inaccuracies of glucose meters occur at the extremes of glucose reportable range (critical values), but in this region the most important and potentially life-threatening decisions concerning therapy must be made.” Vasquez, J. 2005
“Published reports and clinical experience suggest that glucose meters may not be the most accurate and could possibly result in inappropriate insulin dose titration and avoidable adverse events related to glycemic control.” Kanji, S. 2005
“The magnitude of the differences in the glucose values offered by the four different methods of glucose measurement led to frequent clinical disagreements regarding insulin dose titration in the context of an insulin infusion protocol for aggressive glucose control.”
Kanji, S. 2005
Kanji S et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med , Vol.33, No 12, 2005
Vasquez, J et al. Investigating the reliability of POCT glucose meters, Clinical Chemistry, Vol. 51, No. 6, Supplement, 2005
Glucose Management of Hospitalized Patients Demands Improved Glucose Strip Performance
Confidential
1. Boyd, JD and Bruns, DE. Quality Specifications for Glucose Meters: Assessment by Simulation Modeling of Errors in Insulin Dose. Clinical Chemistry, 47:2,209-214, 2001
Glucose Management of Hospitalized Patients Demands Improved Glucose Strip Performance
Glucose Error Leads To Insulin Dosing Error1
Total Analytical
Error
InsulinDosage Error
Rate 5% 8-23%
10% 16-45%
15% >5% 2-Step Dosing Error
Confidential
35
94
LifeScan
Cumulative
35
80
98100
Roche
Cumulative
98% of Nova Results Satisfy a 10% Total Error Limit
N=133 patient study at Mayo ClinicNova StatStrip, Lifescan SureStep, Abbott Precision, Roche Inform
Versus Reference Method
Data analysis from Karon, B. et al, Diabetes Technology and Therapeutics, April 2008; not addressed in publication
ADA SpecificationISO 15197 Requirement
% Bias(Error)
Cumulative
Abbott
≤5%
75 26
≤15% 100 76
≤25% 100≤30%
StatStrip
Cumulative
71 67≤10%
98 56
100 96≤20% 93
ADA
ISO 15197
% of patients % of patients % of patients % of patients
Confidential
Fast and Easy Glucose Testing at the Bedside
Confidential
On/Off Button
Function Keys
Bar Code Scanner
Bright, Easy-to-ReadColor Touchscreen.
Large Easy-to-UseTouchpad.
Strip Port
Confidential
Fastest Results, 6 seconds
Sample Volume, 1.2 µL– Easier sample acquisition
– Enables use of less painful lancets
Fewest Operator Steps– No calibration codes or calibration chips
– Strip lot entered automatically by default setting
– Built-in 1D or 2D barcode scanner
StatStrip® Connectivity Meter
Confidential
Color Touch Screen Prompts Operator Through Steps
MED4
MED4
Confidential
Operator ID Entered by Scan or Touch Screen
MED4
Confidential
Meter Then Goes Directly to Patient Test Screen
MED4
Confidential
Strip Lot Scanned or Entered Automatically By Default Setting
35475932MED4
Confidential
Patient ID (or MRN) Entered by Scan or Touch Screen
194546646MED4
Confidential
StatStrip® Confirms Valid Patient ID
194546646
MED4
Confidential
Operator Prompted To Final Step
MED4
Confidential
Results In Only 6 Seconds
MED4
Confidential
Results screen displays all information–Patient ID–Strip Lot–Time–Operator ID
Color, symbols and text alloweasy recognition of normal,abnormal and critical ranges
Operator can reject results at the meter –Repeat testing–Optional set-up
MED4
Confidential
Operator selects comments from a pull-down list or enters via free text
Comments pull-down list customized by:– Meter location– QC, test or sample type
Meters can be configured for mandatory comments
Multiple comments can be entered for each result
Comments can be designated as chartable or non-chartable
MED4
MED4
Confidential
Manual Test Entry
Enables electronic capture of non-connected POC tests using StatStrip infrastructure (ie urinalysis, pregnancy…)
Undefined number of manual tests configurable
Manual tests are configurable by hospital– pre-configured list for results– Numeric, – +/-
Captures QC for manual tests
Validate lot numbers
Confidential
Provides network connection for data downloading and meter configuration
Charges batteries
StatStrip® Docking Station
Confidential
Comprehensive features for infection control StatStrip’s durable case has passed the FDA’s rigorous disinfection
testing protocol validate with 10,950 cleaning cycles using commercially available cleaning materials including bleach.
StatStrip’s disposable, protective bags are available for infection control. Patient barcode scanning and meter operation can be performed with the meter inside the protective bag.
Software workflow and operating steps are optimized for infection control:
Operator ID and strip lot number are scanned and test strips pre-loaded into the meter outside the patient room
The carrying case and extra testing supplies remain outside
the patient room per CMS recommendation.
Confidential
StatStrip® Installation Examples
Nova StatStrip® Healthcare Systems Include:
Intermountain Health Care System, UT (900+ meters)
Manitoba Regional Healthcare, CN (855 meters)
William Beaumont Medical Center, MI (379 meters)
Johns Hopkins, MD (310 meters)
Baptist Health South Florida, FL (250 meters)
Northshore University Health System, IL (250 meters)
Scripps Health, CA (400 meters)
ROi, MO (1000 meters)
Yale New Haven Health System, CT (500 meters)
Duke University Health System, NC (400 meters)
Kaiser Health, USA (2500 meters)
Confidential
Largest Healthcare System Implementation
Intermountain Healthcare System, UT
- 21 Hospitals
- 60+ clinics
- 900+ meters
- 8,000+ operators trained
StatStrip® Installation Examples
Confidential
Reimbursement
Confidential
StatStrip® CPT Code
Confidential
StatStrip is the only glucose test strip developed specifically for professional use in the hospital, and cleared by the FDA for that intended use. The reimbursement code for StatStrip® is 82947.
Two CPT codes for glucose:82947 – Quantitative; glucose, blood $5.62 (StatStrip®)
82962 – Glucose; blood by monitoring device -$3.27 (FDA cleared specifically for home use)Additional reimbursement for CPT Code #82947 $2.35
At an outpatient usage of 5%, hospital revenues would increase by the following amounts over a 5 year contract Five Year Approximate Increased TotalStrip Usage Meters in Use Hospital Revenue2 million 80 $235,0004 million 160 $470,0006 million 240 $705,0008 million 320 $940,000
StatStrip® Reimbursement
(All other glucose strips)
Confidential
Connectivity Overview
Confidential
Scalable connectivity from single hospital to multi-hospital systems Provides a single connectivity solution for all POC device types
- Both wired and wireless connections- Manual test entry of off line tests
Comprehensive data management and reporting tools
Single device-type fee for StatStrip and StatSensor meters
StatStrip and StatSensor meters eliminate the need for costly terminal server devices (Lantronix, Dawning).
Comprehensive, Cost Effective POC Connectivity
Confidential
Op: 8636
13:42Meter Name: NICU-1
OK
Enter Patient ID
_________________________
Clear
1 2 34 5 67 8 9
ABC...0Scan
Accept
194546646
Meters Meter Configuration
Lab/Hospital Information
Systems
Data Management
Nova Connects
Confidential
Control of point-of-care devices, operators and usage for compliance with point-of-care program requirements
Capture of point-of-care data for analyzing, reporting and sharing
Connect point-of-care testing to multiple data receivers including LIS, HIS and EMR
Compatible with all “Open Connectivity” to all middleware providers
Confidential
StatStrip® meters can be customized by location
– Assign operators and privileges– Assign normal, abnormal and critical
ranges – Assign mandatory fields– Establish download/docking
requirements– Establish QC requirements
• Pass/fail or numeric option, • QC frequency, lockout or
prompting– Flag results for Tight Glycemic
Control– Reject results for repeat testing– Structure patient ID or MRN
NovaNet Instrument Manager
Management and Control of Bedside Glucose Testing
Confidential
Program coordinator can send a text message to specific operator or group of operators with an optional “I read this message” acknowledgment
Multiple options for appending comments to patient or QC results – By meter location– By QC or test type– Preset or free text– Chartable or non-chartable
NovaNet Instrument Manager
Management and Control of Bedside Glucose Testing
Confidential
NovaConnects: Manual Test Entry
Manual test results can be entered through the StatStrip touch screen interface.
Data is captured through NovaConnects infrastructure
Manual tests are configurable by the hospital- Manual tests can be quantitative or qualitative- QC is also captured
An unlimited number of manual tests can be configured
Confidential
Integrated Management and Control of Bedside Testing
Nova has worked with virtually all LIS and HIS vendors to provide fully integrated connectivity solutions that include:
Complete data management and reporting
Operator certification management
Electronic (EDI) or scripted interfacing
Full support for unsolicited result reporting to the LIS
Hospital defined rules for result exception management
Consolidated interface for all connected POC device types
Confidential
Capture all data for patient, device, operator andregulatory records Create standard or customized reports from a large report libraryResults exceptionsInterface exceptionsResults repository QA statisticsLevy-JenningsProgram utilizationOperator Certifications Turnaround TimeResults ReportsProtocol ReportsProgram Summary
Device Summary: Active devices, device location assignment, last uploadOperations reports including;
Operator recertification due, Daily workload, Device error events,Overdue device docking, Reporting exceptions.
Confidential
Flexible network connections meet variable needs throughout hospital
Confidential
Nova Wireless Connectivity OptionsWireless Bridge
- Wireless connection from docking station provides access to Wifi network.- Cost effective vs. installing new network drops- Uses Cisco Linksys WET-200, or other off-the-shelf components- Not Portable
Nova Wireless Tote - Integrated docking station and transmitter in tote - “Always On” connection - Portable - No meter connectivity reconfiguration - Rechargeable battery
Confidential
Enables connections to all POC devices, regardless of manufacture
Eliminates connectivity lock-out which limits POC device choice.
Allows hospitals to make POC device decisions based on deviceneeds and benefits Removes cost of middleware conversion as a barrier to acquiringnew POC devices
Non-proprietary, Open Connectivity
Confidential
Proven success with virtually every LIS and HIS vendor
Electronic Data Interface (EDI) or Script-in enables unsolicited results reporting into LIS or HIS
Provides a single interface for virtually all POC devices from all vendors
Manages data flow by hospital-specific exceptions rules
Nova ConnectsTM
and Telcor, Inc. or Alere Informatics
Confidential
Telcor QMLQML provides
- Complete data management
- ADT data messaging to NovaNet for positive patient ID at the meter
- Hospital defined rules for result exception management
- Consolidated interface for all connected POC device types
Confidential
Alere Informatics-RALSRALS provides
- Complete data management- ADT data messaging for positive patient ID at the meter- Hospital defined rules for results exception management- Consolidated interface for all connected POC device types
Confidential
“The StatStrip glucose meter correlated best with a plasma hexokinase reference method over a wide range of glucose concentrations and was least significantly impacted by sample hematocrit and other interfering substances. This should allow for better management of critically ill patients on intensive insulin therapy resulting in better glycemic control with improved outcomes and patient safety..”
StatStrip®
Multi-Well Technology CreatesA New Level of Analytical Performance
Karon, B. et al, Diabetes Technology and Therapeutics, Apr 2008;
TM
Confidential
Thank You
Hospital Glucose Monitoring System
Hospital Glucose Meter
Hospital Glucose Meter